A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
Public ClinicalTrials.gov record NCT00094432. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Aripiprazole in the Treatment of Patients With Bipolar I Disorder With a Major Depressive Episode. CN138-146 LT is the 26-week Open Label Extension Phase of the Above Titled Protocol, CN138-146 ST.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate several doses of aripiprazole in patients with bipolar depression.
Study identification
- NCT ID
- NCT00094432
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 650 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2004 (Type not available)
- Primary completion
- Nov 2006 (Actual)
- Completion
- Nov 2006 (Actual)
- Last update posted
- Nov 11, 2013
2004 – 2006
United States locations
- U.S. sites
- 40
- U.S. states
- 23
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Mesa | Arizona | — | — |
| Local Institution | La Mesa | California | — | — |
| Local Institution | La Palma | California | — | — |
| Local Institution | Long Beach | California | — | — |
| Local Institution | Redlands | California | — | — |
| Local Institution | San Diego | California | — | — |
| Local Institution | Sherman Oaks | California | — | — |
| Local Institution | Washington D.C. | District of Columbia | — | — |
| Local Institution | Coral Springs | Florida | — | — |
| Local Institution | Jacksonville | Florida | — | — |
| Local Institution | St. Petersburg | Florida | — | — |
| Local Institution | Marietta | Georgia | — | — |
| Local Institution | Edwardsville | Illinois | — | — |
| Local Institution | Oak Brook | Illinois | — | — |
| Local Institution | Springfield | Illinois | — | — |
| Local Institution | Lafayette | Indiana | — | — |
| Local Institution | Newton | Kansas | — | — |
| Local Institution | New Orleans | Louisiana | — | — |
| Local Institution | Shreveport | Louisiana | — | — |
| Local Institution | Baltimore | Maryland | — | — |
| Local Institution | St Louis | Missouri | — | — |
| Local Institution | Clementon | New Jersey | — | — |
| Local Institution | Albuquerque | New Mexico | — | — |
| Local Institution | Brooklyn | New York | — | — |
| Local Institution | Elmsford | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | Raleigh | North Carolina | — | — |
| Local Institution | Dayton | Ohio | — | — |
| Local Institution | Media | Pennsylvania | — | — |
| Local Institution | Philadelphia | Pennsylvania | — | — |
| Local Institution | Pittsburgh | Pennsylvania | — | — |
| Local Institution | Columbia | South Carolina | — | — |
| Local Institution | DeSoto | Texas | — | — |
| Local Institution | Houston | Texas | — | — |
| Local Institution | Wichita Falls | Texas | — | — |
| Local Institution | Salt Lake City | Utah | — | — |
| Local Institution | Charlottesville | Virginia | — | — |
| Local Institution | Midlothian | Virginia | — | — |
| Local Institution | Bellevue | Washington | — | — |
| Local Institution | Charleston | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00094432, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2013 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00094432 live on ClinicalTrials.gov.